Pfizer Inc (PFE)

PFE on New York Consolidated

33.37USD
2 Jul 2015
Change (% chg)

-- (--)
Prev Close
$33.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
23,736,775
52-wk High
$35.53
52-wk Low
$27.51

PFE

Chart for PFE

About

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX,... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $205,481.50
Shares Outstanding(Mil.): 6,157.67
Dividend: 0.28
Yield (%): 3.36

Financials

  PFE Industry Sector
P/E (TTM): 23.08 35.83 39.81
EPS (TTM): 1.45 -- --
ROI: 6.44 17.03 16.23
ROE: 12.69 17.93 17.36
Search Stocks

Exclusive: Hospira wins French biosimilar drug tender at 45 percent discount

PARIS - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn's disease and psoriasis in a victory for a new type of medicine known as biosimilars.   

03 Jul 2015

Canada's Valeant approaches to buy Zoetis: WSJ

- Canada-based drugmaker Valeant Pharmaceuticals International Inc has approached to buy Zoetis Inc , an animal-health company, the Wall Street Journal reported.

25 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

GSK sells two vaccines to Pfizer to ease competition concerns

LONDON, June 22 - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.

22 Jun 2015

U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

UPDATE 2-U.S. jury clears Pfizer in second trial alleging Zoloft birth defects

NEW YORK, June 11 - A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits.

11 Jun 2015

U.S. jury clears Pfizer in second trial over Zoloft

NEW YORK, June 11 - A U.S. jury on Thursday found Pfizer Inc not liable in a lawsuit claiming its antidepressant Zoloft caused birth defects in an eight-year old girl whose mother took the drug while pregnant, according to a company spokeswoman.

11 Jun 2015

Merck KGaA sees immunotherapy drug holding its own in cancer race

FRANKFURT - The head of Merck KGaA's healthcare division said she expected its cancer drug avelumab, jointly developed with Pfizer, to be among the first two or three to market in a field of immunotherapy pharmaceuticals that harness the power of the immune system in a range of cancer types.

01 Jun 2015

Merck KGaA sees immunotherapy drug holding its own in cancer race

FRANKFURT, June 1 - The head of Merck KGaA's healthcare division said she expected its cancer drug avelumab, jointly developed with Pfizer, to be among the first two or three to market in a field of immunotherapy pharmaceuticals that harness the power of the immune system in a range of cancer types.

01 Jun 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $98.44 -0.03
Novartis AG (NOVN.VX) CHF92.60 -0.45
Merck & Co., Inc. (MRK.N) $57.67 +0.07
Roche Holding Ltd. (ROG.VX) CHF264.60 -0.50
Abbott Laboratories (ABT.N) $49.41 -0.11
Bayer AG (BAYGn.DE) €123.65 -2.20
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €87.60 -0.58
AstraZeneca plc (AZN.L) 4,190.00p +23.00
GlaxoSmithKline plc (GSK.L) 1,353.42p +5.50

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks